Bacterial Co-infections and Antibacterial therapy in retrospective COVID-19 patients in AL Fallujah General Teaching Hospital

Authors

  • AL-Karbolii M. M

DOI:

https://doi.org/10.37506/ijfmt.v15i3.15578

Keywords:

Bacterial Co-infections, antibacterial therapy, COVID-19

Abstract

In order to determine a retrospective study data were collected from all 2031 COVID-19 patients detected
by PCR (nasal swap) from January/ 2020- January /2021 for Fallujah General Teaching Hospital ,which total
number of Positive covid19 were 210 in isolation ward and Negative number of COVID-19 were 1821.The
study condense on bacterial co-infections and antibacterial therapy for this bacteria. Clinical information
were : the genera females were 60 ( 28.5%) and were males 150 (71.4%). microbiological detected isolation
from blood sample through 48hour of 210 COVID-19 patients in isolation ward detected by BACT/ALERT®
Culture Media(1)then cultured on routine bacteriological media according to(2)for positive growth isolated
bacteria then identification were done by biochemical test. The result of bacterial isolation from blood of
patients assumptive co-infections among 210 samples, positive growth isolated of bacteria which were 121
(57,6%) and included S. pneumoniae , S. aureus , S. epidermidis, K. pneumoniae, p. aeroginosa and E. coli
and total negative isolated which indeed enclose 89 (42.3%). Depending on ABS achieve guidelines, the
most commonly used antibiotic way was Meropenem, Azithromycin and Cefixime with a median duration of
6 (range 1–13) days in isolation ward and when using Antibiotic Susceptibility test expressed each resistant
and sensitive bacteria to antibiotic discs for all positive isolate and detected by sensitivity patterns of VITEK2
system to some species as ensuring method, but; the study focus on co-infection had the highest frequency
of Staphylococcus aureus 57 (47.1%) isolates which were resistant to Ciprofloxacin, Chloramphenicol,
Gentamycin, Amikacin, azithromycin, Cefotaxime, tetracycline ,Trimethoprim/ Sulphamethoxazole and
sensitive to Levofloxacin and imipenem.

Author Biography

AL-Karbolii M. M

Scholar Researcher, DVM, MSC, Epidemiology & Infectious, Zoonotic Diseases, Serology and Bacteriology unit in
Laboratory of Fallujah General Teaching Hospital, Iraq

Published

2021-05-17

How to Cite

AL-Karbolii M. M. (2021). Bacterial Co-infections and Antibacterial therapy in retrospective COVID-19 patients in AL Fallujah General Teaching Hospital. Indian Journal of Forensic Medicine & Toxicology, 15(3), 1805-1811. https://doi.org/10.37506/ijfmt.v15i3.15578